Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Marta, Zamora"'
Autor:
Marta Zamora Troncoso
Publikováno v:
Fedro, Vol 1, Iss 22 (2022)
Reseña sobre Manuel Barrios Casares, La vida como ensayo y otros ensayos. Kundera, Benjamin, Ortega. Athenaica Ediciones, Sevilla, 2021.
Externí odkaz:
https://doaj.org/article/d61b3074fee349678614dd8c3d050b3e
Autor:
Juan R. Cajal-Calvo, Carlota M. Bello-Franco, Raquel Navas-Campo, Leticia Moreno-Caballero, Marta Zamora-Lozano, Javier Salceda-Artola
Publikováno v:
Revista Argentina de Radiología, Vol 86, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/898c5a4d7d68479dab775b8dddc8dcde
Publikováno v:
Anales de Pediatría, Vol 96, Iss 5, Pp 461-462 (2022)
Externí odkaz:
https://doaj.org/article/0ed350314c8946bbbe56716aeaedef00
Autor:
Kiranj Chaudagar, Hanna M. Hieromnimon, Rimpi Khurana, Brian Labadie, Taghreed Hirz, Shenglin Mei, Raisa Hasan, Jordan Shafran, Anne Kelley, Eva Apostolov, Ghamdan Al-Eryani, Kate Harvey, Srikrishnan Rameshbabu, Mayme Loyd, Kaela Bynoe, Catherine Drovetsky, Ani Solanki, Erica Markiewicz, Marta Zamora, Xiaobing Fan, Stephan Schürer, Alex Swarbrick, David B. Sykes, Akash Patnaik
Publikováno v:
Clinical Cancer Research. 29:1952-1968
Purpose: Phosphatase and tensin homolog (PTEN) loss of function occurs in approximately 50% of patients with metastatic castrate-resistant prostate cancer (mCRPC), and is associated with poor prognosis and responsiveness to standard-of-care therapies
Publikováno v:
Revista de la Facultad de Ciencias Médicas de Córdoba, Vol 78, Iss 1 (2021)
Introducción: El granuloma eosinófilo es una enfermedad benigna poco usual que suele afectar a la población pediátrica y adultos jóvenes. Es la afección más benigna de las enfermedades tradicionalmente conocidas como histiocitosis X que en la
Externí odkaz:
https://doaj.org/article/6c91dedddd004b1d92e17251d9134467
Autor:
Maria Marta Zamora Rodríguez
Publikováno v:
Emancipação, Vol 17, Iss 2, Pp 265-273 (2017)
El presente artículo ha sido elaborado con base en la revisión bibliográfica realizada como parte del trabajo de asistente en el proyecto “Movilización de mujeres campesinas en la lucha por la recuperación de tierras en dos comunidades de Los
Externí odkaz:
https://doaj.org/article/9ba3cdc145884311b57ad71579ac197f
Autor:
Devkumar Mustafi, Abby Leinroth, Xiaobing Fan, Erica Markiewicz, Marta Zamora, Jeffrey Mueller, Suzanne D. Conzen, Gregory S. Karczmar
Publikováno v:
International Journal of Biomedical Imaging, Vol 2019 (2019)
Breast cancer is a major cause of morbidity and mortality in Western women. Tumor neoangiogenesis, the formation of new blood vessels from pre-existing ones, may be used as a prognostic marker for cancer progression. Clinical practice uses dynamic co
Externí odkaz:
https://doaj.org/article/492896f1d1bd4a62a034ff2d0d1aead1
Autor:
Akash Patnaik, David B. Sykes, Alex Swarbrick, Stephan Schürer, Xiaobing Fan, Marta Zamora, Erica Markiewicz, Ani Solanki, Catherine Drovetsky, Kaela Bynoe, Mayme Loyd, Srikrishnan Rameshbabu, Kate Harvey, Ghamdan Al-Eryani, Eva Apostolov, Anne Kelley, Jordan Shafran, Raisa Hasan, Shenglin Mei, Taghreed Hirz, Brian Labadie, Rimpi Khurana, Hanna M. Hieromnimon, Kiranj Chaudagar
Purpose:Phosphatase and tensin homolog (PTEN) loss of function occurs in approximately 50% of patients with metastatic castrate-resistant prostate cancer (mCRPC), and is associated with poor prognosis and responsiveness to standard-of-care therapies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cabfb09a9cb30f9f1e328f0b008a53c6
https://doi.org/10.1158/1078-0432.c.6563227.v1
https://doi.org/10.1158/1078-0432.c.6563227.v1
Autor:
Akash Patnaik, David B. Sykes, Alex Swarbrick, Stephan Schürer, Xiaobing Fan, Marta Zamora, Erica Markiewicz, Ani Solanki, Catherine Drovetsky, Kaela Bynoe, Mayme Loyd, Srikrishnan Rameshbabu, Kate Harvey, Ghamdan Al-Eryani, Eva Apostolov, Anne Kelley, Jordan Shafran, Raisa Hasan, Shenglin Mei, Taghreed Hirz, Brian Labadie, Rimpi Khurana, Hanna M. Hieromnimon, Kiranj Chaudagar
Supplementary Figure S1. The majority of Pb-Cre; PTENfl/fl Trp53fl/fl mice are de novo resistant to ADT. Supplementary Figure S2. ADT/PI3Ki combination therapy halts prostate tumor growth up to 14 days, followed by development of resistance in majori
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998c4977bf8201764c79ff7057327293
https://doi.org/10.1158/1078-0432.22551388
https://doi.org/10.1158/1078-0432.22551388
Autor:
Akash Patnaik, David B. Sykes, Alex Swarbrick, Stephan Schürer, Xiaobing Fan, Marta Zamora, Erica Markiewicz, Ani Solanki, Catherine Drovetsky, Kaela Bynoe, Mayme Loyd, Srikrishnan Rameshbabu, Kate Harvey, Ghamdan Al-Eryani, Eva Apostolov, Anne Kelley, Jordan Shafran, Raisa Hasan, Shenglin Mei, Taghreed Hirz, Brian Labadie, Rimpi Khurana, Hanna M. Hieromnimon, Kiranj Chaudagar
Supplementary Table S1. ADT + PI3Ki + PD-1 antibody leads to TAM activation within TME of PTEN/p53-deficient prostate tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d9c9f9283500d5546fd5f95fd33e150
https://doi.org/10.1158/1078-0432.22551385
https://doi.org/10.1158/1078-0432.22551385